Enveda, an AI drugmaker, banks $311M in venture funding
Published . Updated .
Enveda, which is using AI tools to mine plants and microbes for drug prospects, has three candidates in human testing for immune diseases and obesity.
Directly affected
- No company is named in this report.
Indirectly affected
- SUPX SUPERX AI TECHNOLOGY LTD
GA selected SUPX as a RELATED security because its canonical security name directly matches this event's themes: technology, ai. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ABAT AMERICAN BATTERY TECHNOLOGY
GA selected ABAT as a RELATED security because its canonical security name directly matches this event's themes: technology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ACHC ACADIA HEALTHCARE COMPANY INC
GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ACM AECOM TECHNOLOGY CORP
GA selected ACM as a RELATED security because its canonical security name directly matches this event's themes: technology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- ALLY ALLY FINANCIAL INC
GA selected ALLY as a RELATED security because its canonical security name directly matches this event's themes: financial. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
- AOSL ALPHA & OMEGA SEMICONDUCTOR LT SHS
GA selected AOSL as a RELATED security because its canonical security name directly matches this event's themes: semiconductor. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
Price reaction, T-5 to T+3
Enveda, which is using AI tools to mine plants and microbes for drug prospects, has three candidates in human testing for immune diseases and obesity.
Source: BioPharma Dive
The price since 23 Sep 2026: SuperX AI Technology (SUPX) versus the S&P 500
Since the first closing price after “Enveda, an AI drugmaker, banks $311M in venture funding,” SuperX AI Technology (SUPX) is -2.82%. The S&P 500 fund (SPY) is -0.09% over the same days, a -2.73% difference versus the market.
Disclosure records for SuperX AI Technology (SUPX) within two months of 23 Sep 2026
- Donald J Trump buy Aecom (ACM) ($1,001 - $15,000). That is 26 days before publication, inside 30 days. The filing is listed beside the story “Enveda, an AI drugmaker, banks $311M in venture funding.”
- Donald J Trump sell Aecom (ACM) ($1,001 - $15,000). That is 30 days before publication, inside 30 days. The filing is listed beside the story “Enveda, an AI drugmaker, banks $311M in venture funding.”
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Taiwan Strait, seven days against thirty
Taiwan Strait has 48 linked stories in the last 7 days and 48 in the last 30 on the page that also carries “Enveda, an AI drugmaker, banks $311M in venture funding.” The recent pace is rising.
Who is named in “Enveda, an AI drugmaker, banks $311M in venture funding”
Companies carried with this story
- SUPX SuperX AI Technology
In “Enveda, an AI drugmaker, banks $311M in venture funding,” SuperX AI Technology (SUPX) is linked, with no stored direction, medium confidence. Reason on file: GA selected SUPX as a RELATED security because its canonical security name directly matches this event's themes: technology, ai. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ABAT American Battery Technology
For “Enveda, an AI drugmaker, banks $311M in venture funding,” American Battery Technology (ABAT) is linked, with no stored direction, medium confidence. Reason on file: GA selected ABAT as a RELATED security because its canonical security name directly matches this event's themes: technology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ACHC Acadia Healthcare
In “Enveda, an AI drugmaker, banks $311M in venture funding,” Acadia Healthcare (ACHC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACHC as a RELATED security because its canonical security name directly matches this event's themes: healthcare. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ACM Aecom
In “Enveda, an AI drugmaker, banks $311M in venture funding,” Aecom (ACM) is linked, with no stored direction, medium confidence. Reason on file: GA selected ACM as a RELATED security because its canonical security name directly matches this event's themes: technology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- ALLY Ally Financial
Ally Financial (ALLY) is linked, with no stored direction, medium confidence in the 23 Sep 2026 story “Enveda, an AI drugmaker, banks $311M in venture funding.” Reason on file: GA selected ALLY as a RELATED security because its canonical security name directly matches this event's themes: financial. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
- AOSL Alpha & Omega Semiconductor
For “Enveda, an AI drugmaker, banks $311M in venture funding,” Alpha & Omega Semiconductor (AOSL) is linked, with no stored direction, medium confidence. Reason on file: GA selected AOSL as a RELATED security because its canonical security name directly matches this event's themes: semiconductor. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
How “Enveda, an AI drugmaker, banks $311M in venture funding” reaches SuperX AI Technology (SUPX)
SuperX AI Technology (SUPX) is the company in “Enveda, an AI drugmaker, banks $311M in venture funding,” the 23 Sep 2026 Taiwan Strait story.
SuperX AI Technology (SUPX) is on the page because GA selected SUPX as a RELATED security because its canonical security name directly matches this event's themes: technology, ai. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
Also listed, American Battery Technology (ABAT): GA selected ABAT as a RELATED security because its canonical security name directly matches this event's themes: technology. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
The price range for SuperX AI Technology (SUPX), and the dates in the story
ABAT traded between 1.42 and 2.42 across 20 sessions. The latest close on file is 1.44. ACHC traded between 26.75 and 32.03 across 20 sessions. The latest close on file is 30.20. SUPX traded between 6.15 and 7.09 across 10 sessions. The latest close on file is 6.72.
A simple score for SuperX AI Technology (SUPX)
46 out of 100
“Enveda, an AI drugmaker, banks $311M in venture funding” scores 46 out of 100. The score uses 1 sources, and 6 linked companies.